Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review

Pharmacology, Biochemistry, and Behavior
S H KollinsC R Rush

Abstract

Methylphenidate (MPH) is widely used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents, and adults. Methylphenidate is clearly effective for the treatment of ADHD, but there is controversy as to whether it has significant abuse potential like other psychostimulants (e.g., D-amphetamine and cocaine). In general, the drug is believed to be abused at rates much lower than those for other stimulants. The present review examines studies that investigated the behavioral pharmacological profile of methylphenidate and discusses how results from these studies address its abuse liability. Using MEDLINE search terms methylphenidate, drug discrimination, reinforcement, self-administration, subjective effects, subject-rated effects, abuse potential, and abuse liability, along with a review of the references from identified articles, 60 studies were located in which the reinforcing, discriminative-stimulus, or subjective effects of methylphenidate were directly assessed in nonhumans or humans. Forty-eight (80.0%) of the studies reviewed indicate that methylphenidate either functions in a manner similar to D-amphetamine or cocaine (e.g., functions as a reinforcer, substitutes fully in drug discrimin...Continue Reading

References

Jan 1, 1979·Pharmacology, Biochemistry, and Behavior·T G Aigner, R L Balster
Sep 17, 1975·Psychopharmacologia·M E Risner, B E Jones
Sep 1, 1977·Archives of General Psychiatry·W A Brown
Apr 11, 1991·Archives of Internal Medicine·T V Parran, D R Jasinski
Jan 1, 1991·Psychopharmacology·S J Heishman, J E Henningfield
Sep 1, 1989·Journal of the American Academy of Child and Adolescent Psychiatry·B BirmaherB Maminski
Feb 1, 1986·Pharmacology, Biochemistry, and Behavior·J B RosenR T Louis-Ferdinand
Jan 1, 1987·Psychopharmacology·A H Tang, S R Franklin
Sep 1, 1986·Journal of Analytical Toxicology·B LevineG Kauffman
Apr 15, 1985·Brain Research·M T Martin-IversonH C Fibiger
Sep 1, 1974·Pharmacology, Biochemistry, and Behavior·J T Huang, B T Ho
Jan 1, 1984·Psychopharmacology·R J CollinsR R Russell
Feb 1, 1980·Psychopharmacology·C N JonesS T McBennett
Jan 1, 1980·Psychopharmacology·C E Johanson, E H Uhlenhuth
Jan 1, 1983·Neuropharmacology·M W Emmett-OglesbyH Lal
Mar 1, 1980·Neuropharmacology·M L McKenna, B T Ho
Jul 1, 1997·Pharmacology, Biochemistry, and Behavior·R H MachT E Morton
Aug 1, 1997·Psychopharmacology·A S WardR W Foltin
Dec 31, 1997·Journal of Clinical Psychopharmacology·J GrabowskiA Korszun
Apr 4, 1998·Experimental and Clinical Psychopharmacology·A M PersicoG R Uhl
Jun 17, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·E J Garland
Jul 2, 1998·Journal of Developmental and Behavioral Pediatrics : JDBP·C J MusserN Mueller-Rizner
Jul 25, 1998·Pharmacology, Biochemistry, and Behavior·R Young, R A Glennon

❮ Previous
Next ❯

Citations

May 17, 2008·Psychopharmacology·Leigh C P BotlyPaul J Fletcher
Aug 21, 2013·Journal of Religion and Health·Scott J FitzpatrickDeepak Sarma
Feb 25, 2009·Advances in Therapy·Wim VerbeeckGeertruida E Bekkering
Jul 19, 2005·Addictive Behaviors·Sean Esteban McCabe, Carol J Boyd
Dec 8, 2004·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Sean Esteban McCabeSally K Guthrie
Jan 24, 2004·Life Sciences·B Prieto-GomezN Dafny
Nov 20, 2003·Neuroscience and Biobehavioral Reviews·J M Swanson, N D Volkow
Aug 15, 2002·Pharmacology, Biochemistry, and Behavior·Susan Schenk, Sari Izenwasser
Oct 12, 2002·Pharmacology, Biochemistry, and Behavior·Tatiana S BondarevaRichard A Glennon
Jul 20, 2002·Drug and Alcohol Dependence·Craig R RushAdam F Wooten
Dec 7, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Nora D VolkowSamuel J Gatley
Aug 11, 2004·Experimental and Clinical Psychopharmacology·Timothy RoehrsThomas Roth
Jun 16, 2010·Experimental and Clinical Psychopharmacology·Julie A MarusichMichael T Bardo
Aug 14, 2008·Molecular Psychiatry·S M BermanE D London
Nov 5, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Maciej GasiorCarol A Paronis
Jan 8, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Motoyo Yano, Heinz Steiner
May 18, 2013·The International Journal of Clinical and Experimental Hypnosis·Salvador AmigóJoan C Micó
May 10, 2006·Journal of Psychoactive Drugs·Sean Esteban McCabeCarol J Boyd
Feb 22, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Wendy Klein-Schwartz, Jean McGrath
May 1, 2002·Current Opinion in Pediatrics·Wendy Klein-Schwartz
May 1, 2002·Behavioural Pharmacology·C R RushA F Wooten
Mar 30, 2012·Journal of Addiction Medicine·Silvana CastaldiPeter J Schulz
Apr 12, 2007·Behavioural Pharmacology·Samira S ValvassoriJoão Quevedo
Dec 17, 2010·Behavioural Pharmacology·Robin W McGovernWilliam C Griffin
Sep 8, 2011·Behavioural Pharmacology·Julie A MarusichMichael T Bardo
Jun 12, 2010·Journal of Attention Disorders·Aimee L McRae-ClarkRickey E Carter
Jun 13, 2006·Substance Abuse Treatment, Prevention, and Policy·Steve SussmanToby Miller
Sep 8, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Daniel RosenfieldNoni E MacDonald
May 14, 2003·Pharmacotherapy·Christian J TeterSally K Guthrie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.